title: [Strategy for peptic ulcer therapy in the era of H. pylori eradication therapy].
abstract: The Japanese guideline for gastric ulcer therapy published 2003 has adopted a policy that eradication therapy for H. pylori as the first line therapy on ulcer patients with positive H. pylori status. For NSAID-induced gastric ulcer patients, cessation should be considered. In patients who cannot stop NSAIDs, proton-pump inhibitors or prostaglandin drugs is recommended. Similar strategy can be applied for duodenal ulcer patients. Implementation of this basic strategy in daily clinical practice, however, require further efforts to wider recognition of the new guideline for gastric ulcer therapy as well as to solve several barriers caused by discrepant health reimbursement policy.
authors.affiliation: Department of Internal Medicine, Division of Gastroenterology, Jichi Medical School.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Sugano
mesh_terms: D004381:Duodenal Ulcer / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D013276:Stomach Ulcer / Q000188:drug therapy*